Pitt Shield

A quantitative pressure and microbubble-size dependence study of focused ultrasound-induced blood-brain barrier opening reversibility in vivo using MRI.

Authors: Samiotaki G, Vlachos F, Tung YS, Konofagou EE

Focused ultrasound in conjunction with the systemic administration of microbubbles has been shown to open the blood-brain barrier (BBB) selectively, noninvasively and reversibly. In this study, we investigate the dependence of the BBB opening's reversibility on the peak-rarefactional pressure (0.30-0.60 MPa) as well as the microbubble size (diameters of 1-2, 4-5, or 6-8 μm) in mice using contrast-enhanced T(1)-weighted (CE-T(1)) MR images (9.4 T). Volumetric measurements of the diffusion of Gd-DTPA-BMA into the brain parenchyma were used for the quantification of the BBB-opened region on the day of sonication and up to 5 days thereafter. The volume of opening was found to increase with both pressure and microbubble diameter. The duration required for closing was found to be proportional to the volume of opening on the day of opening, and ranged from 24 h, for the smaller microbubbles, to 5 days at high peak-rarefactional pressures. Overall, larger bubbles did not show significant differences. Also, the extent of BBB opening decreased radially towards the focal region until the BBB's integrity was restored. In the cases where histological damage was detected, it was found to be highly correlated with hyperintensity on the precontrast T(1) images.

Introduction

Purpose Drug delivery with BBB opening
Study Objective To investigate how peak-rarefactional pressure and microbubble size affect the volume and reversibility (duration to close) of focused ultrasound–induced blood–brain barrier opening in mice using contrast-enhanced MRI.
Animal model / Human subject Mouse (Mus musculus), strain None, age None, sex None
Disease model healthy
MRI or image guidance method Guided using 9.4 T MRI with contrast-enhanced T1-weighted (CE-T1) imaging for targeting and volumetric measurement of the BBB-opened region
Cargo name and characteristics Gd-DTPA-BMA — a small-molecule, gadolinium-based MRI contrast agent (extracellular, nonionic chelate) used to visualize and quantify BBB opening by contrast-enhanced T1-weighted MRI
Route of administration intravenous (systemic administration of microbubbles and Gd-DTPA-BMA)

Outcomes and Safety

Summary of Outcomes Focused ultrasound with systemically administered microbubbles produced blood–brain barrier openings whose volume increased with peak-rarefactional pressure and microbubble size, with closure time proportional to initial opening volume (ranging from 24 hours to 5 days) and histological damage correlating with pre-contrast T1 hyperintensity.
Duration of biological effect 24 hours to 5 days
Safety-related matter Some cases showed histological damage, which was highly correlated with hyperintensity on pre-contrast T1 images.

Brain Region

Visualization unavailable

Ultrasound Parameters

Ultrasound instrument None.
FUS Intensity 3.0 - 12.0 W/cm2 (calculated from PRP 0.30–0.60 MPa)
FUS Pressure 0.30 MPa - 0.60 MPa
FUS Mode pulsed
Duration of a single FUS session 24 hours to 5 days
Treatment frequency single

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search